Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T C Chan

Showing results (261-270 of 407) with videos related to

Pageof 41
Sort By:
Cancer Chemotherapy and Pharmacology|April 3, 2013
Preclinical evaluation of combined TKI-258 and RAD001 in hepatocellular carcinomaStephen L Chan, Chi-Hang Wong, Cecilia P Y Lau, et al.
International Journal of Radiation Oncology, Biology, Physics|December 14, 2004
Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experienceMichael K M Kam, Peter M L Teo, Ricky M C Chau, et al.
Chinese Journal of Cancer|September 17, 2014
International validation of the Chinese university prognostic index for staging of hepatocellular carcinoma: a joint United Kingdom and Hong Kong studyStephen L Chan, Philip J Johnson, Frankie Mo, et al.
Investigational New Drugs|May 28, 2009
The activity of mTOR inhibitor RAD001 (everolimus) in nasopharyngeal carcinoma and cisplatin-resistant cell linesBrigette B Y Ma, Vivian W Y Lui, Edwin P Hui, et al.
Cancer Chemotherapy and Pharmacology|September 1, 2007
A phase II study of patients with metastatic or locoregionally recurrent nasopharyngeal carcinoma and evaluation of plasma Epstein-Barr virus DNA as a biomarker of efficacyBrigette Ma, Edwin P Hui, Ann King, et al.
Clinical Chemistry|August 21, 2004
Distribution of cell-free and cell-associated Epstein-Barr virus (EBV) DNA in the blood of patients with nasopharyngeal carcinoma and EBV-associated lymphomaLydia C W Lit, K C Allen Chan, Sing-Fai Leung, et al.
Cellular and Molecular Life Sciences : CMLS|October 26, 2013
Epigenetic identification of receptor tyrosine kinase-like orphan receptor 2 as a functional tumor suppressor inhibiting β-catenin and AKT signaling but frequently methylated in common carcinomasLili Li, Jianming Ying, Xin Tong, et al.
Cell Death and Differentiation|February 22, 2023
A novel tumor suppressor encoded by a 1p36.3 lncRNA functions as a phosphoinositide-binding protein repressing AKT phosphorylation/activation and promoting autophagyLili Li, Xing-Sheng Shu, Hua Geng, et al.
Archives of Pathology & Laboratory Medicine|July 10, 2007
The contribution of bifunctional SkipDewax pretreatment solution, rabbit monoclonal antibodies, and polymer detection systems in immunohistochemistrySze Chuen Cesar Wong, John K C Chan, Elena S F Lo, et al.
Cancer Letters|February 27, 2007
Genome-wide expression analysis using microarray identified complex signaling pathways modulated by hypoxia in nasopharyngeal carcinomaFion L Sung, Edwin P Hui, Qian Tao, et al.
Pageof 41

Showing results (261-270 of 407) with videos related to

Sort By:
Pageof 41
Cancer Chemotherapy and Pharmacology|April 3, 2013
Preclinical evaluation of combined TKI-258 and RAD001 in hepatocellular carcinomaStephen L Chan, Chi-Hang Wong, Cecilia P Y Lau, et al.
International Journal of Radiation Oncology, Biology, Physics|December 14, 2004
Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experienceMichael K M Kam, Peter M L Teo, Ricky M C Chau, et al.
Chinese Journal of Cancer|September 17, 2014
International validation of the Chinese university prognostic index for staging of hepatocellular carcinoma: a joint United Kingdom and Hong Kong studyStephen L Chan, Philip J Johnson, Frankie Mo, et al.
Investigational New Drugs|May 28, 2009
The activity of mTOR inhibitor RAD001 (everolimus) in nasopharyngeal carcinoma and cisplatin-resistant cell linesBrigette B Y Ma, Vivian W Y Lui, Edwin P Hui, et al.
Cancer Chemotherapy and Pharmacology|September 1, 2007
A phase II study of patients with metastatic or locoregionally recurrent nasopharyngeal carcinoma and evaluation of plasma Epstein-Barr virus DNA as a biomarker of efficacyBrigette Ma, Edwin P Hui, Ann King, et al.
Clinical Chemistry|August 21, 2004
Distribution of cell-free and cell-associated Epstein-Barr virus (EBV) DNA in the blood of patients with nasopharyngeal carcinoma and EBV-associated lymphomaLydia C W Lit, K C Allen Chan, Sing-Fai Leung, et al.
Cellular and Molecular Life Sciences : CMLS|October 26, 2013
Epigenetic identification of receptor tyrosine kinase-like orphan receptor 2 as a functional tumor suppressor inhibiting β-catenin and AKT signaling but frequently methylated in common carcinomasLili Li, Jianming Ying, Xin Tong, et al.
Cell Death and Differentiation|February 22, 2023
A novel tumor suppressor encoded by a 1p36.3 lncRNA functions as a phosphoinositide-binding protein repressing AKT phosphorylation/activation and promoting autophagyLili Li, Xing-Sheng Shu, Hua Geng, et al.
Archives of Pathology & Laboratory Medicine|July 10, 2007
The contribution of bifunctional SkipDewax pretreatment solution, rabbit monoclonal antibodies, and polymer detection systems in immunohistochemistrySze Chuen Cesar Wong, John K C Chan, Elena S F Lo, et al.
Cancer Letters|February 27, 2007
Genome-wide expression analysis using microarray identified complex signaling pathways modulated by hypoxia in nasopharyngeal carcinomaFion L Sung, Edwin P Hui, Qian Tao, et al.
Pageof 41